West Coast Asset Mgmt Present Its 50% Upside Idea--Noven Pharmaceuticals (NOVN)
More News related to NOVN
- Jefferies & Co Upgrades Noven Pharmaceuticals (NOVN) to Hold
- Noven Announces Results of 2009 Annual Meeting of Stockholders
- Noven to Webcast 2009 Annual Meeting of Stockholders
- Francois Nader, M.D., to Join Noven's Board of Directors
- Noven to Present At Deutsche Bank Health Care Conference
Noven Pharmaceuticals (Nasdaq: NOVN) has 85M in net cash, 10 million in real estate, management has a proven track record. Also, Noven Pharmaceuticals recently announced a $25 million buyback.
West Coast believes Noven Pharmaceuticals should move 50% higher. Noven has a low enterprise value and looks ripe for an investment.
(Reporting From Value Investing Congress)
Related Categories
Analyst CommentsStocks Mentioned
-0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
